Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Tissue Engineering and Regenerative Medicine|May 18, 2022
Emerging tissue engineering strategies for the corneal regenerationMahsa Fallah Tafti, Hossein Aghamollaei, Mehrdad Moosazadeh Moghaddam, et al.
Journal of Ophthalmic & Vision Research|May 26, 2015
Topical cyclosporine a for mustard gas induced ocular surface disordersKhosrow Jadidi, Ali Ebrahimi, Yunes Panahi, et al.
Frontiers in Medicine|November 27, 2025
Correction: AI-driven strategies for advancing corneal cell therapy: a promising frontierMahsa Fallah Tafti, Masoud Khorrami-Nejad, Masoud Arabfard, et al.
Frontiers in Medicine|October 20, 2025
AI-driven strategies for advancing corneal cell therapy: a promising frontierMahsa Fallah Tafti, Masoud Khorrami-Nejad, Masoud Arabfard, et al.
Clinical & Experimental Optometry|March 10, 2021
Long-term results of MyoRing implantation in patients with keratoconusMostafa Naderi, Farshid Karimi, Khosrow Jadidi, et al.
International Ophthalmology|June 3, 2019
Efficacy of complete rings (MyoRing) in treatment of Keratoconus: a systematic review and meta-analysisLeila Janani, Kiarash Tanha, Fereshteh Najafi, et al.
3 Biotech|May 10, 2023
Novel pathogenic <i>CERKL</i> variant in Iranian familial with inherited retinal dystrophies: genotype-phenotype correlationShangyi Fu, Jiewen Fu, Abdolkarim Mobasher-Jannat, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 28, 2019
Use of low-vault posterior chamber collagen copolymer phakic intraocular lenses for the correction of myopia: a 3-year follow-upKhosrow Jadidi, Seyed Aliasghar Mosavi, Farhad Nejat, et al.
BMC Ophthalmology|September 14, 2021
Safety evaluation of the atmospheric low-temperature plasma (ALTP) on the conjunctiva: an animal study and histopathological findings; 6-month follow-upFarhad Nejat, Khosrow Jadidi, Fahimeh Asadi Amoli, et al.
Archives of Biochemistry and Biophysics|June 15, 2025
Design of chiral 2-oxazoline-based amino acid bioConjugates as anticancer agents: Synthesis, in vitro anticancer activity, ADMET prediction with molecular docking and molecular dynamic simulation insightsMasoumehossadat Hosseini, Safura Jokar, Hooman Hefezi, et al.
Pageof 8